Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - mannheimia haemolytica strain nl 1009 - misc. vaccines or anti sera - mannheimia haemolytica strain nl 1009 vaccine-general active 2.0 ml/do - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - respiratory disease | skin lesion

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - mannheimia haemolyticastrains; mannheimia haemolyticastrains; mannheimia haemolyticastrains; mannheimia haemolyticastrains; mannheimia haemolyticastrains; pasteurella trehalosistrains; pasteurella trehalosistrains; pasteurella trehalosistrains; pasteurella trehalosistrains - suspension for injection - 5 x 10^8 cells - pasteurella - sheep - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - inactivated mannheimia haemolytica strain x387; inactivated m. haemolytica leucotoxin strain x332; polymyxin b sulfate; thiomersal - parenteral liquid/solution/suspension - inactivated mannheimia haemolytica strain x387 vaccine - general active 0.0 p; inactivated m. haemolytica leucotoxin strain x332 vaccine - general active 0.0 p; polymyxin b sulfate antibiotic other 0.1 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - respiratory disease

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - mannheimia haemolytica, pasteurella trehalosi - suspension for injection - inactivated bacterial vaccine - sheep

European Union - English - EMA (European Medicines Agency)

ceva santé animale - florfenicol, meloxicam - amphenicols, combinations, antibacterials for systemic use - cattle - for therapeutic treatment of bovine respiratory disease (brd) associated with pyrexia due to mannheimia haemolytica, pasteurella multocida and histophilus somni susceptible to florfenicol.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibacterials for systemic use - pigs; cattle; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis sensitive to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. draxxin should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

elanco gmbh - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - gamithromycin - antibacterials for systemic use - cattle; pigs; sheep - cattletreatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni. the presence of the disease in the herd should be established before metaphylactic use.pigstreatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and bordetella bronchiseptica.sheeptreatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

intervet international bv - tildipirosin - antiinfectives for systemic use - pigs; cattle - 40-mg/ml solution for injection for pigstreatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica and haemophilus parasuis sensitive to tildipirosin.the presence of the disease in the herd should be confirmed before metaphylaxis is implemented.180-mg/ml solution for injection for cattlefor the treatment and prevention of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni sensitive to tildipirosin.the presence of the disease in the herd should be confirmed before preventive treatment.

Israel - English - Ministry of Health

beit-erez havat milatin ltd - gamithromycin - solution for injection - gamithromycin 150 mg/ml - * cattle: therapeutic and preventive treatment (metaphylaxis) of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni.the presence of the disease in the herd should be established before preventive treatment. * pigs (swine): treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida and haemophilus parasuis. * sheep:treatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.